

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.94391535 |
| 2 | modulation by symbiont of host immune response (GO:0052553) | 6.94391535 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 6.94391535 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 6.94391535 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.94391535 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.94391535 |
| 7 | neutrophil activation involved in immune response (GO:0002283) | 5.43567425 |
| 8 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.32570809 |
| 9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.31967349 |
| 10 | macrophage activation involved in immune response (GO:0002281) | 5.03556539 |
| 11 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 5.02840801 |
| 12 | response to peptidoglycan (GO:0032494) | 4.47620516 |
| 13 | positive regulation of interferon-alpha production (GO:0032727) | 4.39910521 |
| 14 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.36784883 |
| 15 | response to host immune response (GO:0052572) | 4.36784883 |
| 16 | respiratory burst (GO:0045730) | 4.32580695 |
| 17 | regulation of interferon-alpha production (GO:0032647) | 4.21861848 |
| 18 | negative regulation of mast cell activation (GO:0033004) | 4.20243751 |
| 19 | oligosaccharide catabolic process (GO:0009313) | 4.15508393 |
| 20 | microglial cell activation (GO:0001774) | 4.05321071 |
| 21 | immunoglobulin mediated immune response (GO:0016064) | 4.02959500 |
| 22 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.90193307 |
| 23 | response to host (GO:0075136) | 3.85220855 |
| 24 | response to host defenses (GO:0052200) | 3.85220855 |
| 25 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.85220855 |
| 26 | superoxide anion generation (GO:0042554) | 3.84458913 |
| 27 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.83561405 |
| 28 | natural killer cell mediated immunity (GO:0002228) | 3.83561405 |
| 29 | positive regulation of interferon-beta production (GO:0032728) | 3.75526455 |
| 30 | macrophage activation (GO:0042116) | 3.73835594 |
| 31 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.73439299 |
| 32 | * glycosphingolipid catabolic process (GO:0046479) | 3.69322126 |
| 33 | positive regulation of antigen processing and presentation (GO:0002579) | 3.66098714 |
| 34 | regulation of mononuclear cell migration (GO:0071675) | 3.64670028 |
| 35 | proteasome assembly (GO:0043248) | 3.64659360 |
| 36 | granulocyte activation (GO:0036230) | 3.62718531 |
| 37 | myeloid cell activation involved in immune response (GO:0002275) | 3.56940390 |
| 38 | regulation of mast cell degranulation (GO:0043304) | 3.51825392 |
| 39 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.48962909 |
| 40 | neutrophil activation (GO:0042119) | 3.44987924 |
| 41 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.43055296 |
| 42 | purine nucleotide salvage (GO:0032261) | 3.41276543 |
| 43 | cellular response to arsenic-containing substance (GO:0071243) | 3.39533429 |
| 44 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.35921806 |
| 45 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.34344187 |
| 46 | regulation of mast cell activation (GO:0033003) | 3.34284773 |
| 47 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.33822814 |
| 48 | regulation of antigen processing and presentation (GO:0002577) | 3.32736319 |
| 49 | * glycolipid catabolic process (GO:0019377) | 3.31423795 |
| 50 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.31138080 |
| 51 | neutrophil mediated immunity (GO:0002446) | 3.30752512 |
| 52 | detection of molecule of bacterial origin (GO:0032490) | 3.24007637 |
| 53 | regulation of podosome assembly (GO:0071801) | 3.20422453 |
| 54 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.14737067 |
| 55 | regulation of chronic inflammatory response (GO:0002676) | 3.13899066 |
| 56 | reactive oxygen species biosynthetic process (GO:1903409) | 3.12498961 |
| 57 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.08786283 |
| 58 | positive regulation of mast cell activation (GO:0033005) | 3.08247726 |
| 59 | leukocyte mediated cytotoxicity (GO:0001909) | 3.07081000 |
| 60 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.06890606 |
| 61 | response to muramyl dipeptide (GO:0032495) | 3.06850428 |
| 62 | phagosome maturation (GO:0090382) | 3.04439701 |
| 63 | B cell mediated immunity (GO:0019724) | 3.03986705 |
| 64 | pinocytosis (GO:0006907) | 3.00743214 |
| 65 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.98961827 |
| 66 | negative regulation of ligase activity (GO:0051352) | 2.95244216 |
| 67 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.95244216 |
| 68 | positive regulation of heat generation (GO:0031652) | 2.94946775 |
| 69 | protein neddylation (GO:0045116) | 2.92678452 |
| 70 | regulation of vitamin metabolic process (GO:0030656) | 2.92353486 |
| 71 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.91695614 |
| 72 | regulation of interferon-beta production (GO:0032648) | 2.88577111 |
| 73 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.86877153 |
| 74 | regulation of leukocyte degranulation (GO:0043300) | 2.85773308 |
| 75 | negative regulation of interleukin-12 production (GO:0032695) | 2.84974502 |
| 76 | purine-containing compound salvage (GO:0043101) | 2.84952962 |
| 77 | amino sugar catabolic process (GO:0046348) | 2.83193224 |
| 78 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.82141137 |
| 79 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.81906291 |
| 80 | * ceramide catabolic process (GO:0046514) | 2.81491970 |
| 81 | regulation of chemokine biosynthetic process (GO:0045073) | 2.80205120 |
| 82 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.79677363 |
| 83 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.78678639 |
| 84 | monocyte chemotaxis (GO:0002548) | 2.77468531 |
| 85 | positive regulation of T cell apoptotic process (GO:0070234) | 2.75759908 |
| 86 | intracellular pH reduction (GO:0051452) | 2.75435870 |
| 87 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.75162189 |
| 88 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.75042194 |
| 89 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.73382767 |
| 90 | positive regulation of chemokine production (GO:0032722) | 2.70769062 |
| 91 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.70441032 |
| 92 | regulation of fever generation (GO:0031620) | 2.70318015 |
| 93 | positive regulation of leukocyte apoptotic process (GO:2000108) | 2.70203976 |
| 94 | purine nucleobase biosynthetic process (GO:0009113) | 2.68992928 |
| 95 | regulation of superoxide anion generation (GO:0032928) | 2.68880568 |
| 96 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.67307789 |
| 97 | cyclooxygenase pathway (GO:0019371) | 2.67107634 |
| 98 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.66887355 |
| 99 | eosinophil chemotaxis (GO:0048245) | 2.65431141 |
| 100 | lymphocyte mediated immunity (GO:0002449) | 2.64292155 |
| 101 | nucleotide salvage (GO:0043173) | 2.63632836 |
| 102 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.62221082 |
| 103 | positive regulation of mast cell degranulation (GO:0043306) | 2.62221082 |
| 104 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.61922578 |
| 105 | * membrane lipid catabolic process (GO:0046466) | 2.61565291 |
| 106 | positive regulation of leukocyte degranulation (GO:0043302) | 2.59647455 |
| 107 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.59589817 |
| 108 | I-kappaB phosphorylation (GO:0007252) | 2.58070512 |
| 109 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.57620229 |
| 110 | protein maturation by protein folding (GO:0022417) | 2.57527009 |
| 111 | myeloid leukocyte activation (GO:0002274) | 2.57162238 |
| 112 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.55204837 |
| 113 | wound healing, spreading of epidermal cells (GO:0035313) | 2.54276131 |
| 114 | cellular extravasation (GO:0045123) | 2.51862584 |
| 115 | * sphingolipid catabolic process (GO:0030149) | 2.51441300 |
| 116 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.50699983 |
| 117 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.50457720 |
| 118 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.49773883 |
| 119 | DNA strand elongation (GO:0022616) | 2.49017634 |
| 120 | sphingosine metabolic process (GO:0006670) | 2.48144196 |
| 121 | phagocytosis, recognition (GO:0006910) | 2.47765503 |
| 122 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.47651157 |
| 123 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.47651157 |
| 124 | hyaluronan catabolic process (GO:0030214) | 2.47052204 |
| 125 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.46837083 |
| 126 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.46837083 |
| 127 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.46837083 |
| 128 | nucleoside salvage (GO:0043174) | 2.45959551 |
| 129 | positive regulation of interleukin-6 production (GO:0032755) | 2.45798413 |
| 130 | actin nucleation (GO:0045010) | 2.45132351 |
| 131 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.44817295 |
| 132 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.44275056 |
| 133 | N-acetylneuraminate metabolic process (GO:0006054) | 2.44091838 |
| 134 | response to thyroid hormone (GO:0097066) | 2.43688644 |
| 135 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.43532413 |
| 136 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.43212372 |
| 137 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.41406200 |
| 138 | myeloid cell homeostasis (GO:0002262) | 2.40808614 |
| 139 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.40763977 |
| 140 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.40763977 |
| 141 | leukocyte mediated immunity (GO:0002443) | 2.39222168 |
| 142 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.39108676 |
| 143 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.38305278 |
| 144 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.38246548 |
| 145 | negative regulation of interleukin-17 production (GO:0032700) | 2.37705601 |
| 146 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.37588217 |
| 147 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.36658133 |
| 148 | cytokine secretion (GO:0050663) | 2.36616682 |
| 149 | negative regulation of interleukin-6 production (GO:0032715) | 2.36400560 |
| 150 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.35888720 |
| 151 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.35610608 |
| 152 | positive regulation of ligase activity (GO:0051351) | 2.34077427 |
| 153 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.32920660 |
| 154 | regulation of growth of symbiont in host (GO:0044126) | 2.32920660 |
| 155 | negative regulation of growth of symbiont in host (GO:0044130) | 2.32920660 |
| 156 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.32920660 |
| 157 | eosinophil migration (GO:0072677) | 2.32776603 |
| 158 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.32654503 |
| 159 | IMP biosynthetic process (GO:0006188) | 2.31762233 |
| 160 | pentose metabolic process (GO:0019321) | 2.29504170 |
| 161 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.28788434 |
| 162 | NIK/NF-kappaB signaling (GO:0038061) | 2.28769884 |
| 163 | negative regulation of lipid storage (GO:0010888) | 2.26277045 |
| 164 | polyamine biosynthetic process (GO:0006596) | 2.23826438 |
| 165 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.22271456 |
| 166 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.22111590 |
| 167 | lipoxygenase pathway (GO:0019372) | 2.21357156 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.00480462 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.96848409 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.68649326 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.23832830 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.75357206 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.59922776 |
| 7 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.41890307 |
| 8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.22952149 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.16755888 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.91747965 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.87329081 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.78883642 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.57427753 |
| 14 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.31931605 |
| 15 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.19612065 |
| 16 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.18405453 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.16666203 |
| 18 | TFEB_21752829_ChIP-Seq_HELA_Human | 2.11374662 |
| 19 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.08882547 |
| 20 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.02663404 |
| 21 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.00264262 |
| 22 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.99791250 |
| 23 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.98286232 |
| 24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.89243269 |
| 25 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.88158243 |
| 26 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.87806098 |
| 27 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.82048317 |
| 28 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.79331434 |
| 29 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.78695052 |
| 30 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.76201575 |
| 31 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.75902423 |
| 32 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.69810684 |
| 33 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.67706398 |
| 34 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.62193607 |
| 35 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.61483616 |
| 36 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.61139018 |
| 37 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.60928097 |
| 38 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.59157827 |
| 39 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.55612207 |
| 40 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.55433515 |
| 41 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54659116 |
| 42 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.54272008 |
| 43 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52527703 |
| 44 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.51902418 |
| 45 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.51856276 |
| 46 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.50796949 |
| 47 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.49417817 |
| 48 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.49339898 |
| 49 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.47352705 |
| 50 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.46916781 |
| 51 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.44276270 |
| 52 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.43624565 |
| 53 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.42924528 |
| 54 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.39428365 |
| 55 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.37543199 |
| 56 | MYB_26560356_Chip-Seq_TH2_Human | 1.32342218 |
| 57 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.32196062 |
| 58 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.29514264 |
| 59 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.28047474 |
| 60 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.27314040 |
| 61 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.26574160 |
| 62 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.25576341 |
| 63 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.24701014 |
| 64 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23626758 |
| 65 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.23223450 |
| 66 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.22279640 |
| 67 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.21662455 |
| 68 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.20358449 |
| 69 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20158350 |
| 70 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.19867925 |
| 71 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19861580 |
| 72 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19453797 |
| 73 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17879035 |
| 74 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.17594399 |
| 75 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16269361 |
| 76 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.16147001 |
| 77 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15854722 |
| 78 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.15379377 |
| 79 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.13965824 |
| 80 | MYB_26560356_Chip-Seq_TH1_Human | 1.12527936 |
| 81 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.10674537 |
| 82 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10529039 |
| 83 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.09647360 |
| 84 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09525921 |
| 85 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.08999136 |
| 86 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.08941021 |
| 87 | SPI1_23127762_ChIP-Seq_K562_Human | 1.08404200 |
| 88 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.07770099 |
| 89 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.07189945 |
| 90 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.07125585 |
| 91 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.06545453 |
| 92 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.05893729 |
| 93 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.05857853 |
| 94 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.05744467 |
| 95 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.04962113 |
| 96 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.04229460 |
| 97 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.04187264 |
| 98 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.01392154 |
| 99 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.01124902 |
| 100 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00855292 |
| 101 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99436698 |
| 102 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.99048904 |
| 103 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.98711766 |
| 104 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.98432004 |
| 105 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.98276925 |
| 106 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.97187251 |
| 107 | MAF_26560356_Chip-Seq_TH1_Human | 0.95821651 |
| 108 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.95720087 |
| 109 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.95704247 |
| 110 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95701774 |
| 111 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.95357595 |
| 112 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94743947 |
| 113 | GATA3_26560356_Chip-Seq_TH2_Human | 0.94252214 |
| 114 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.94007447 |
| 115 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.92698928 |
| 116 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.92524706 |
| 117 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91948794 |
| 118 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.90855341 |
| 119 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.88438172 |
| 120 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.86988691 |
| 121 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.86300768 |
| 122 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.85149557 |
| 123 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.84838830 |
| 124 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.83707213 |
| 125 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.82505334 |
| 126 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.80990512 |
| 127 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.80786567 |
| 128 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.79583008 |
| 129 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.79583008 |
| 130 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.79147348 |
| 131 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.79068950 |
| 132 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.78368304 |
| 133 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.75717470 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 4.51340200 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 3.72639696 |
| 3 | MP0003303_peritoneal_inflammation | 3.56873366 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.36291873 |
| 5 | MP0003436_decreased_susceptibility_to | 3.26066934 |
| 6 | MP0006082_CNS_inflammation | 3.05360272 |
| 7 | MP0002419_abnormal_innate_immunity | 2.99011502 |
| 8 | MP0003172_abnormal_lysosome_physiology | 2.96821448 |
| 9 | MP0005257_abnormal_intraocular_pressure | 2.67247497 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.66177992 |
| 11 | MP0009785_altered_susceptibility_to | 2.58289372 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.56143651 |
| 13 | MP0000569_abnormal_digit_pigmentation | 2.38588230 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.31541282 |
| 15 | MP0003724_increased_susceptibility_to | 2.30816988 |
| 16 | MP0005025_abnormal_response_to | 2.27661908 |
| 17 | MP0009840_abnormal_foam_cell | 2.22023721 |
| 18 | MP0010307_abnormal_tumor_latency | 2.20011387 |
| 19 | MP0002139_abnormal_hepatobiliary_system | 2.09688269 |
| 20 | MP0003448_altered_tumor_morphology | 2.08523475 |
| 21 | MP0001533_abnormal_skeleton_physiology | 2.03774208 |
| 22 | MP0002723_abnormal_immune_serum | 2.03766885 |
| 23 | MP0001790_abnormal_immune_system | 2.01534874 |
| 24 | MP0005387_immune_system_phenotype | 2.01534874 |
| 25 | MP0001800_abnormal_humoral_immune | 1.94953226 |
| 26 | MP0008260_abnormal_autophagy | 1.94756787 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 1.92770222 |
| 28 | MP0003693_abnormal_embryo_hatching | 1.88029936 |
| 29 | MP0005464_abnormal_platelet_physiology | 1.87143750 |
| 30 | MP0001819_abnormal_immune_cell | 1.86053987 |
| 31 | MP0002420_abnormal_adaptive_immunity | 1.84452297 |
| 32 | MP0008004_abnormal_stomach_pH | 1.83017894 |
| 33 | MP0004510_myositis | 1.77803858 |
| 34 | MP0005671_abnormal_response_to | 1.77493955 |
| 35 | MP0002405_respiratory_system_inflammati | 1.68689853 |
| 36 | MP0004947_skin_inflammation | 1.63270530 |
| 37 | MP0006054_spinal_hemorrhage | 1.62277444 |
| 38 | MP0002998_abnormal_bone_remodeling | 1.61731396 |
| 39 | MP0000015_abnormal_ear_pigmentation | 1.61027720 |
| 40 | MP0008438_abnormal_cutaneous_collagen | 1.59936154 |
| 41 | MP0001845_abnormal_inflammatory_respons | 1.58603614 |
| 42 | MP0005174_abnormal_tail_pigmentation | 1.55982002 |
| 43 | MP0005310_abnormal_salivary_gland | 1.55904563 |
| 44 | MP0001853_heart_inflammation | 1.55294715 |
| 45 | MP0000858_altered_metastatic_potential | 1.52091668 |
| 46 | MP0000343_altered_response_to | 1.48394401 |
| 47 | MP0000685_abnormal_immune_system | 1.45733464 |
| 48 | MP0000604_amyloidosis | 1.45143471 |
| 49 | MP0000716_abnormal_immune_system | 1.36465061 |
| 50 | MP0008469_abnormal_protein_level | 1.33910045 |
| 51 | MP0001542_abnormal_bone_strength | 1.31535236 |
| 52 | MP0006036_abnormal_mitochondrial_physio | 1.30789076 |
| 53 | MP0000689_abnormal_spleen_morphology | 1.28649255 |
| 54 | MP0002277_abnormal_respiratory_mucosa | 1.28194778 |
| 55 | MP0008007_abnormal_cellular_replicative | 1.27886392 |
| 56 | MP0003111_abnormal_nucleus_morphology | 1.26955531 |
| 57 | MP0009764_decreased_sensitivity_to | 1.23718636 |
| 58 | MP0002398_abnormal_bone_marrow | 1.23535148 |
| 59 | MP0005390_skeleton_phenotype | 1.23148410 |
| 60 | MP0005167_abnormal_blood-brain_barrier | 1.21936990 |
| 61 | MP0005165_increased_susceptibility_to | 1.19822081 |
| 62 | MP0001851_eye_inflammation | 1.15210390 |
| 63 | MP0003300_gastrointestinal_ulcer | 1.14943682 |
| 64 | MP0009278_abnormal_bone_marrow | 1.14643818 |
| 65 | MP0002722_abnormal_immune_system | 1.14189023 |
| 66 | MP0002429_abnormal_blood_cell | 1.13665239 |
| 67 | MP0010155_abnormal_intestine_physiology | 1.12037586 |
| 68 | MP0009763_increased_sensitivity_to | 1.11458017 |
| 69 | MP0001545_abnormal_hematopoietic_system | 1.07813698 |
| 70 | MP0005397_hematopoietic_system_phenotyp | 1.07813698 |
| 71 | MP0003077_abnormal_cell_cycle | 1.07443707 |
| 72 | MP0003186_abnormal_redox_activity | 1.06792861 |
| 73 | MP0003191_abnormal_cellular_cholesterol | 1.06347829 |
| 74 | MP0003828_pulmonary_edema | 1.06088161 |
| 75 | MP0000490_abnormal_crypts_of | 1.05869703 |
| 76 | MP0003690_abnormal_glial_cell | 1.05793533 |
| 77 | MP0002396_abnormal_hematopoietic_system | 1.04939533 |
| 78 | MP0002933_joint_inflammation | 1.01934541 |
| 79 | MP0009765_abnormal_xenobiotic_induced | 1.01726593 |
| 80 | MP0005164_abnormal_response_to | 1.00278518 |
| 81 | MP0000465_gastrointestinal_hemorrhage | 0.97621952 |
| 82 | MP0006035_abnormal_mitochondrial_morpho | 0.97174710 |
| 83 | MP0004782_abnormal_surfactant_physiolog | 0.96223142 |
| 84 | MP0005076_abnormal_cell_differentiation | 0.96065095 |
| 85 | MP0003183_abnormal_peptide_metabolism | 0.95884761 |
| 86 | MP0005166_decreased_susceptibility_to | 0.95858823 |
| 87 | MP0003195_calcinosis | 0.94830732 |
| 88 | MP0001958_emphysema | 0.94690297 |
| 89 | * MP0000358_abnormal_cell_content/ | 0.94644328 |
| 90 | MP0003566_abnormal_cell_adhesion | 0.94042651 |
| 91 | MP0010352_gastrointestinal_tract_polyps | 0.93305645 |
| 92 | MP0008932_abnormal_embryonic_tissue | 0.92213825 |
| 93 | MP0001764_abnormal_homeostasis | 0.91433091 |
| 94 | MP0003075_altered_response_to | 0.89782140 |
| 95 | MP0000313_abnormal_cell_death | 0.89422119 |
| 96 | MP0005410_abnormal_fertilization | 0.89281209 |
| 97 | MP0002006_tumorigenesis | 0.88691515 |
| 98 | MP0002090_abnormal_vision | 0.88170611 |
| 99 | MP0005647_abnormal_sex_gland | 0.87666864 |
| 100 | MP0000371_diluted_coat_color | 0.87143799 |
| 101 | MP0002332_abnormal_exercise_endurance | 0.85312821 |
| 102 | MP0003795_abnormal_bone_structure | 0.84619026 |
| 103 | MP0004808_abnormal_hematopoietic_stem | 0.84187775 |
| 104 | MP0001727_abnormal_embryo_implantation | 0.82677572 |
| 105 | MP0003786_premature_aging | 0.80436094 |
| 106 | MP0004883_abnormal_blood_vessel | 0.79227175 |
| 107 | MP0008057_abnormal_DNA_replication | 0.78856974 |
| 108 | MP0003718_maternal_effect | 0.78434983 |
| 109 | MP0005319_abnormal_enzyme/_coenzyme | 0.78015432 |
| 110 | MP0003656_abnormal_erythrocyte_physiolo | 0.76552515 |
| 111 | MP0003453_abnormal_keratinocyte_physiol | 0.76409226 |
| 112 | MP0002019_abnormal_tumor_incidence | 0.75332776 |
| 113 | MP0008058_abnormal_DNA_repair | 0.73870118 |
| 114 | MP0004957_abnormal_blastocyst_morpholog | 0.72647382 |
| 115 | MP0002254_reproductive_system_inflammat | 0.71304039 |
| 116 | MP0002166_altered_tumor_susceptibility | 0.70163483 |
| 117 | MP0005023_abnormal_wound_healing | 0.70102250 |
| 118 | MP0010094_abnormal_chromosome_stability | 0.69620361 |
| 119 | MP0002837_dystrophic_cardiac_calcinosis | 0.68740409 |
| 120 | MP0005451_abnormal_body_composition | 0.68607812 |
| 121 | MP0005621_abnormal_cell_physiology | 0.67517762 |
| 122 | MP0005365_abnormal_bile_salt | 0.66921473 |
| 123 | MP0005197_abnormal_uvea_morphology | 0.66839695 |
| 124 | MP0010386_abnormal_urinary_bladder | 0.66037245 |
| 125 | MP0002877_abnormal_melanocyte_morpholog | 0.65360049 |
| 126 | MP0003091_abnormal_cell_migration | 0.65186819 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.45551261 |
| 2 | Eczematoid dermatitis (HP:0000976) | 6.02360433 |
| 3 | Increased cerebral lipofuscin (HP:0011813) | 5.89548402 |
| 4 | Vacuolated lymphocytes (HP:0001922) | 5.70525896 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 5.64908605 |
| 6 | Abnormality of macrophages (HP:0004311) | 5.53044484 |
| 7 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.12441817 |
| 8 | Abnormality of glycolipid metabolism (HP:0010969) | 5.12272875 |
| 9 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.12272875 |
| 10 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.12272875 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.99229103 |
| 12 | Dysostosis multiplex (HP:0000943) | 4.20907551 |
| 13 | Purpura (HP:0000979) | 3.93338639 |
| 14 | Disinhibition (HP:0000734) | 3.88097626 |
| 15 | Axonal loss (HP:0003447) | 3.82392152 |
| 16 | Prostate neoplasm (HP:0100787) | 3.67348221 |
| 17 | Stomatitis (HP:0010280) | 3.53964339 |
| 18 | Mediastinal lymphadenopathy (HP:0100721) | 3.53579088 |
| 19 | Systemic lupus erythematosus (HP:0002725) | 3.49935578 |
| 20 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.43929099 |
| 21 | Mucopolysacchariduria (HP:0008155) | 3.43929099 |
| 22 | Agnosia (HP:0010524) | 3.43916881 |
| 23 | Gingivitis (HP:0000230) | 3.42434304 |
| 24 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.37041331 |
| 25 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.37041331 |
| 26 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.37041331 |
| 27 | Recurrent skin infections (HP:0001581) | 3.36028188 |
| 28 | * Chronic obstructive pulmonary disease (HP:0006510) | 3.33181829 |
| 29 | * Obstructive lung disease (HP:0006536) | 3.33181829 |
| 30 | Myositis (HP:0100614) | 3.29578490 |
| 31 | Optic neuritis (HP:0100653) | 3.26451492 |
| 32 | Retrobulbar optic neuritis (HP:0100654) | 3.26451492 |
| 33 | Orchitis (HP:0100796) | 3.24806619 |
| 34 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.14091042 |
| 35 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.02898736 |
| 36 | Osteolytic defects of the hand bones (HP:0009699) | 3.02898736 |
| 37 | Recurrent fungal infections (HP:0002841) | 3.02070695 |
| 38 | Hepatosplenomegaly (HP:0001433) | 3.00134392 |
| 39 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.00125065 |
| 40 | Vertebral compression fractures (HP:0002953) | 2.79470881 |
| 41 | Autoimmune thrombocytopenia (HP:0001973) | 2.78395062 |
| 42 | Increased serum ferritin (HP:0003281) | 2.77522444 |
| 43 | Basal ganglia calcification (HP:0002135) | 2.71188715 |
| 44 | Pustule (HP:0200039) | 2.66097864 |
| 45 | Loss of speech (HP:0002371) | 2.65149660 |
| 46 | Personality changes (HP:0000751) | 2.62310743 |
| 47 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.60187170 |
| 48 | Paralysis (HP:0003470) | 2.59793069 |
| 49 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.57414793 |
| 50 | Acute necrotizing encephalopathy (HP:0006965) | 2.56682300 |
| 51 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.50670575 |
| 52 | Periodontitis (HP:0000704) | 2.49045812 |
| 53 | Eosinophilia (HP:0001880) | 2.47470238 |
| 54 | Leukocytosis (HP:0001974) | 2.47234131 |
| 55 | * Nausea (HP:0002018) | 2.45821870 |
| 56 | 3-Methylglutaconic aciduria (HP:0003535) | 2.44164322 |
| 57 | Tetraparesis (HP:0002273) | 2.44001308 |
| 58 | Nuclear cataract (HP:0100018) | 2.43385370 |
| 59 | Renal Fanconi syndrome (HP:0001994) | 2.42932745 |
| 60 | Multiple enchondromatosis (HP:0005701) | 2.42308553 |
| 61 | Abnormality of the anterior horn cell (HP:0006802) | 2.41875025 |
| 62 | Degeneration of anterior horn cells (HP:0002398) | 2.41875025 |
| 63 | Generalized aminoaciduria (HP:0002909) | 2.41441873 |
| 64 | Recurrent pneumonia (HP:0006532) | 2.38545582 |
| 65 | Petechiae (HP:0000967) | 2.37992705 |
| 66 | Interstitial pulmonary disease (HP:0006530) | 2.37747520 |
| 67 | Glomerulonephritis (HP:0000099) | 2.36801622 |
| 68 | Prolonged neonatal jaundice (HP:0006579) | 2.35322150 |
| 69 | Osteomyelitis (HP:0002754) | 2.35195456 |
| 70 | Prolonged bleeding time (HP:0003010) | 2.34416456 |
| 71 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.33628541 |
| 72 | Urticaria (HP:0001025) | 2.33327509 |
| 73 | Poor head control (HP:0002421) | 2.32861797 |
| 74 | Upper motor neuron abnormality (HP:0002127) | 2.32357601 |
| 75 | Abnormality of lateral ventricle (HP:0030047) | 2.30648353 |
| 76 | Thick nail (HP:0001805) | 2.29978903 |
| 77 | Metaphyseal irregularity (HP:0003025) | 2.27526240 |
| 78 | Mitochondrial inheritance (HP:0001427) | 2.26591246 |
| 79 | Abnormality of iron homeostasis (HP:0011031) | 2.25992221 |
| 80 | Recurrent cutaneous fungal infections (HP:0011370) | 2.25355588 |
| 81 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.25355588 |
| 82 | Acute encephalopathy (HP:0006846) | 2.24016131 |
| 83 | Increased CSF lactate (HP:0002490) | 2.23908703 |
| 84 | J-shaped sella turcica (HP:0002680) | 2.22289896 |
| 85 | Cellulitis (HP:0100658) | 2.20302609 |
| 86 | Mutism (HP:0002300) | 2.19502665 |
| 87 | Recurrent viral infections (HP:0004429) | 2.18438202 |
| 88 | Bone pain (HP:0002653) | 2.17343357 |
| 89 | Pathologic fracture (HP:0002756) | 2.16630180 |
| 90 | Diminished motivation (HP:0000745) | 2.14420518 |
| 91 | Granulocytopenia (HP:0001913) | 2.12820924 |
| 92 | Submucous cleft hard palate (HP:0000176) | 2.10355879 |
| 93 | Abnormality of eosinophils (HP:0001879) | 2.09998501 |
| 94 | Type I transferrin isoform profile (HP:0003642) | 2.08168617 |
| 95 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.07917057 |
| 96 | Vasculitis (HP:0002633) | 2.07352881 |
| 97 | Pulmonary infiltrates (HP:0002113) | 2.06787162 |
| 98 | Cervical subluxation (HP:0003308) | 2.06514915 |
| 99 | Premature rupture of membranes (HP:0001788) | 2.06492219 |
| 100 | Apathy (HP:0000741) | 2.05770827 |
| 101 | Increased IgM level (HP:0003496) | 2.04842927 |
| 102 | Increased mean platelet volume (HP:0011877) | 2.02828239 |
| 103 | Albinism (HP:0001022) | 2.01810583 |
| 104 | Recurrent lower respiratory tract infections (HP:0002783) | 2.01617734 |
| 105 | Peripheral demyelination (HP:0011096) | 2.01450282 |
| 106 | Abnormality of the prostate (HP:0008775) | 1.99052105 |
| 107 | Abnormal platelet volume (HP:0011876) | 1.96603407 |
| 108 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.95895910 |
| 109 | Progressive visual loss (HP:0000529) | 1.95452288 |
| 110 | Spondylolisthesis (HP:0003302) | 1.95317144 |
| 111 | Epistaxis (HP:0000421) | 1.95026633 |
| 112 | Cheilitis (HP:0100825) | 1.94369928 |
| 113 | Progressive macrocephaly (HP:0004481) | 1.94120359 |
| 114 | Esophageal neoplasm (HP:0100751) | 1.90955791 |
| 115 | Neoplasm of head and neck (HP:0012288) | 1.90955791 |
| 116 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.90485256 |
| 117 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.90485256 |
| 118 | Hepatocellular necrosis (HP:0001404) | 1.90197462 |
| 119 | Meningitis (HP:0001287) | 1.87304063 |
| 120 | Respiratory failure (HP:0002878) | 1.87095124 |
| 121 | Progressive neurologic deterioration (HP:0002344) | 1.85068327 |
| 122 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.83667180 |
| 123 | Hepatic necrosis (HP:0002605) | 1.82730534 |
| 124 | Progressive muscle weakness (HP:0003323) | 1.82665087 |
| 125 | Ragged-red muscle fibers (HP:0003200) | 1.82318216 |
| 126 | Arterial thrombosis (HP:0004420) | 1.82012671 |
| 127 | Hypokinesia (HP:0002375) | 1.81958987 |
| 128 | Rough bone trabeculation (HP:0100670) | 1.81281830 |
| 129 | Microvesicular hepatic steatosis (HP:0001414) | 1.80032039 |
| 130 | Aseptic necrosis (HP:0010885) | 1.79493418 |
| 131 | * Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.78586224 |
| 132 | Abnormal trabecular bone morphology (HP:0100671) | 1.77252542 |
| 133 | Increased serum lactate (HP:0002151) | 1.77139825 |
| 134 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.76995474 |
| 135 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.75916715 |
| 136 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.75916715 |
| 137 | Abnormal protein glycosylation (HP:0012346) | 1.75916715 |
| 138 | Abnormal glycosylation (HP:0012345) | 1.75916715 |
| 139 | Hematochezia (HP:0002573) | 1.75374668 |
| 140 | Inappropriate behavior (HP:0000719) | 1.74645574 |
| 141 | Tinnitus (HP:0000360) | 1.74177575 |
| 142 | Lactic acidosis (HP:0003128) | 1.73915522 |
| 143 | Increased intramyocellular lipid droplets (HP:0012240) | 1.73801572 |
| 144 | Neuronal loss in central nervous system (HP:0002529) | 1.73667887 |
| 145 | Premature loss of primary teeth (HP:0006323) | 1.72989449 |
| 146 | Persistence of primary teeth (HP:0006335) | 1.70851056 |
| 147 | Entropion (HP:0000621) | 1.70230037 |
| 148 | Keratoconjunctivitis sicca (HP:0001097) | 1.66235196 |
| 149 | Global brain atrophy (HP:0002283) | 1.64740363 |
| 150 | Gingival bleeding (HP:0000225) | 1.64084597 |
| 151 | Neurodegeneration (HP:0002180) | 1.60606156 |
| 152 | Birth length less than 3rd percentile (HP:0003561) | 1.58856127 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 5.07968323 |
| 2 | IRAK4 | 3.29664361 |
| 3 | BLK | 3.22150750 |
| 4 | PBK | 3.16171644 |
| 5 | MAP3K14 | 2.95665290 |
| 6 | PDK2 | 2.94083818 |
| 7 | KIT | 2.54111193 |
| 8 | TBK1 | 2.53365394 |
| 9 | RIPK4 | 2.45832512 |
| 10 | BUB1 | 2.40928258 |
| 11 | TYK2 | 2.36509609 |
| 12 | IKBKB | 2.18655924 |
| 13 | EIF2AK1 | 2.17699008 |
| 14 | PIM2 | 2.07689959 |
| 15 | NME2 | 2.03315496 |
| 16 | GRK7 | 1.99589173 |
| 17 | NEK9 | 1.92516170 |
| 18 | PLK4 | 1.75708132 |
| 19 | ABL2 | 1.73389247 |
| 20 | MAP3K11 | 1.72809668 |
| 21 | IKBKE | 1.69199858 |
| 22 | WEE1 | 1.63473631 |
| 23 | ZAK | 1.62838251 |
| 24 | VRK2 | 1.62220086 |
| 25 | MAP4K1 | 1.53199171 |
| 26 | NEK1 | 1.49869645 |
| 27 | RPS6KA4 | 1.47850963 |
| 28 | EIF2AK3 | 1.46603711 |
| 29 | TAOK3 | 1.45372111 |
| 30 | CDC7 | 1.39334442 |
| 31 | ACVR1B | 1.39157688 |
| 32 | JAK1 | 1.37731211 |
| 33 | ZAP70 | 1.34420189 |
| 34 | TXK | 1.31466809 |
| 35 | EIF2AK2 | 1.31437170 |
| 36 | EPHA2 | 1.25918116 |
| 37 | JAK3 | 1.22907606 |
| 38 | PIM1 | 1.21392138 |
| 39 | TRIM28 | 1.17180400 |
| 40 | CHUK | 1.16028217 |
| 41 | CSF1R | 1.15383792 |
| 42 | SIK3 | 1.14165582 |
| 43 | LYN | 1.05934835 |
| 44 | EPHB1 | 1.05701528 |
| 45 | TEC | 1.04820369 |
| 46 | HCK | 1.04422559 |
| 47 | CSK | 0.99602048 |
| 48 | DDR2 | 0.99272957 |
| 49 | ADRBK2 | 0.99079124 |
| 50 | STK4 | 0.99072823 |
| 51 | STK10 | 0.96944342 |
| 52 | STK3 | 0.94964626 |
| 53 | MARK3 | 0.93035198 |
| 54 | DYRK3 | 0.92685194 |
| 55 | PAK4 | 0.92522636 |
| 56 | SYK | 0.90901919 |
| 57 | FES | 0.90404052 |
| 58 | FGR | 0.87900273 |
| 59 | LCK | 0.87847749 |
| 60 | MAP3K12 | 0.87802707 |
| 61 | SCYL2 | 0.86924816 |
| 62 | TAOK1 | 0.86510111 |
| 63 | BMPR2 | 0.83683735 |
| 64 | TESK2 | 0.83604214 |
| 65 | TESK1 | 0.83216065 |
| 66 | ERN1 | 0.81973871 |
| 67 | NEK2 | 0.81203798 |
| 68 | STK16 | 0.80892644 |
| 69 | MKNK1 | 0.78256631 |
| 70 | BCKDK | 0.76765191 |
| 71 | RPS6KA5 | 0.76139830 |
| 72 | SRPK1 | 0.75347255 |
| 73 | TGFBR2 | 0.73985341 |
| 74 | CSNK1G3 | 0.73623178 |
| 75 | CHEK2 | 0.70455882 |
| 76 | BMX | 0.69845614 |
| 77 | ALK | 0.69824938 |
| 78 | TLK1 | 0.68378915 |
| 79 | DAPK3 | 0.68016022 |
| 80 | YES1 | 0.67967950 |
| 81 | MAP2K3 | 0.67091377 |
| 82 | ABL1 | 0.66834852 |
| 83 | DAPK1 | 0.66777418 |
| 84 | TRPM7 | 0.65457981 |
| 85 | BRSK2 | 0.63731401 |
| 86 | TSSK6 | 0.63221160 |
| 87 | EPHA3 | 0.62611059 |
| 88 | PLK1 | 0.61544239 |
| 89 | PLK3 | 0.61530296 |
| 90 | KDR | 0.61417875 |
| 91 | PRKCD | 0.60686919 |
| 92 | AURKA | 0.60456338 |
| 93 | NUAK1 | 0.59258953 |
| 94 | MAP3K8 | 0.58593788 |
| 95 | CLK1 | 0.58499305 |
| 96 | IRAK1 | 0.58100979 |
| 97 | JAK2 | 0.56476696 |
| 98 | TTK | 0.55233011 |
| 99 | ARAF | 0.54509871 |
| 100 | MATK | 0.54123355 |
| 101 | MKNK2 | 0.53999349 |
| 102 | STK24 | 0.53944193 |
| 103 | TAOK2 | 0.52755374 |
| 104 | AKT3 | 0.52452919 |
| 105 | BTK | 0.51973976 |
| 106 | MAP3K5 | 0.51492697 |
| 107 | CAMKK2 | 0.50929583 |
| 108 | ILK | 0.50719363 |
| 109 | CSNK1A1L | 0.49615338 |
| 110 | ERBB3 | 0.48793433 |
| 111 | BMPR1B | 0.48722413 |
| 112 | CSNK2A1 | 0.47560216 |
| 113 | CDK7 | 0.44380152 |
| 114 | MAP3K13 | 0.44172639 |
| 115 | IRAK2 | 0.44149596 |
| 116 | EGFR | 0.43841747 |
| 117 | MOS | 0.43565866 |
| 118 | NME1 | 0.42853905 |
| 119 | MAPKAPK2 | 0.42638894 |
| 120 | ATR | 0.42116652 |
| 121 | VRK1 | 0.41527622 |
| 122 | BRAF | 0.41519124 |
| 123 | LIMK1 | 0.40910515 |
| 124 | MAP3K3 | 0.40637693 |
| 125 | AURKB | 0.40585687 |
| 126 | CCNB1 | 0.40281986 |
| 127 | CDK6 | 0.39427034 |
| 128 | ITK | 0.38516421 |
| 129 | FGFR3 | 0.37818577 |
| 130 | MAPKAPK3 | 0.36742290 |
| 131 | MST4 | 0.34476736 |
| 132 | PAK1 | 0.33933945 |
| 133 | CSNK1G2 | 0.33646803 |
| 134 | BRSK1 | 0.33402519 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Lysosome_Homo sapiens_hsa04142 | 3.28553007 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.09940463 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.77840919 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.44738286 |
| 5 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.26744000 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.22991503 |
| 7 | Phagosome_Homo sapiens_hsa04145 | 2.18545545 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.15755682 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.15167008 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.10694764 |
| 11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.09906567 |
| 12 | Tuberculosis_Homo sapiens_hsa05152 | 2.08033654 |
| 13 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.04348044 |
| 14 | Legionellosis_Homo sapiens_hsa05134 | 1.96451576 |
| 15 | Proteasome_Homo sapiens_hsa03050 | 1.86099731 |
| 16 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.85654257 |
| 17 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.84986689 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.78700176 |
| 19 | Malaria_Homo sapiens_hsa05144 | 1.77126781 |
| 20 | Pertussis_Homo sapiens_hsa05133 | 1.72087530 |
| 21 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.71281030 |
| 22 | Parkinsons disease_Homo sapiens_hsa05012 | 1.58099637 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.54637523 |
| 24 | Apoptosis_Homo sapiens_hsa04210 | 1.49527475 |
| 25 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.46412543 |
| 26 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.44319759 |
| 27 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.41546149 |
| 28 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.39273554 |
| 29 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.38183404 |
| 30 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.37629092 |
| 31 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.37130218 |
| 32 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.34872626 |
| 33 | Asthma_Homo sapiens_hsa05310 | 1.31039828 |
| 34 | Influenza A_Homo sapiens_hsa05164 | 1.29844607 |
| 35 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.25990128 |
| 36 | RNA polymerase_Homo sapiens_hsa03020 | 1.24783740 |
| 37 | Salmonella infection_Homo sapiens_hsa05132 | 1.24212007 |
| 38 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.23528015 |
| 39 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.23491169 |
| 40 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.21307839 |
| 41 | Allograft rejection_Homo sapiens_hsa05330 | 1.21297321 |
| 42 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.18206226 |
| 43 | Shigellosis_Homo sapiens_hsa05131 | 1.16501377 |
| 44 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.12441584 |
| 45 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.11827084 |
| 46 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.11660133 |
| 47 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.10154812 |
| 48 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.07504607 |
| 49 | Homologous recombination_Homo sapiens_hsa03440 | 1.06231941 |
| 50 | DNA replication_Homo sapiens_hsa03030 | 1.05827929 |
| 51 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.05652498 |
| 52 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.05110491 |
| 53 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.04059136 |
| 54 | Ribosome_Homo sapiens_hsa03010 | 1.03654602 |
| 55 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.02764713 |
| 56 | * Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.02092410 |
| 57 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.00444859 |
| 58 | Hepatitis B_Homo sapiens_hsa05161 | 0.96831752 |
| 59 | Huntingtons disease_Homo sapiens_hsa05016 | 0.96043392 |
| 60 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.95951136 |
| 61 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.94884501 |
| 62 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.88284498 |
| 63 | Bladder cancer_Homo sapiens_hsa05219 | 0.87349563 |
| 64 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.85361378 |
| 65 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.83586358 |
| 66 | Alzheimers disease_Homo sapiens_hsa05010 | 0.83488931 |
| 67 | Mismatch repair_Homo sapiens_hsa03430 | 0.81534619 |
| 68 | Hepatitis C_Homo sapiens_hsa05160 | 0.80463257 |
| 69 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.80085080 |
| 70 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.79041069 |
| 71 | RNA transport_Homo sapiens_hsa03013 | 0.77615423 |
| 72 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.76423690 |
| 73 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.76323620 |
| 74 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.74350995 |
| 75 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.73566783 |
| 76 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.72938260 |
| 77 | Cell cycle_Homo sapiens_hsa04110 | 0.72093627 |
| 78 | * Galactose metabolism_Homo sapiens_hsa00052 | 0.71851678 |
| 79 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.71170858 |
| 80 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.71098656 |
| 81 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.70320975 |
| 82 | * Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.69579156 |
| 83 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.68950574 |
| 84 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.68319308 |
| 85 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.68244587 |
| 86 | Purine metabolism_Homo sapiens_hsa00230 | 0.68038950 |
| 87 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.67335660 |
| 88 | Protein export_Homo sapiens_hsa03060 | 0.67196661 |
| 89 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.64301169 |
| 90 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.64162609 |
| 91 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.61480572 |
| 92 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57897070 |
| 93 | Base excision repair_Homo sapiens_hsa03410 | 0.57873375 |
| 94 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.57723875 |
| 95 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.57089013 |
| 96 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.56686766 |
| 97 | Amoebiasis_Homo sapiens_hsa05146 | 0.55338754 |
| 98 | Mineral absorption_Homo sapiens_hsa04978 | 0.55105913 |
| 99 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.54649744 |
| 100 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.53959198 |
| 101 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53548965 |
| 102 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.53369761 |
| 103 | Basal transcription factors_Homo sapiens_hsa03022 | 0.50486587 |
| 104 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.50180478 |
| 105 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.49439506 |
| 106 | Carbon metabolism_Homo sapiens_hsa01200 | 0.48516152 |
| 107 | Sulfur relay system_Homo sapiens_hsa04122 | 0.48507183 |
| 108 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.47819626 |
| 109 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.47797805 |
| 110 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.47419215 |
| 111 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.47000882 |
| 112 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.46513610 |
| 113 | Spliceosome_Homo sapiens_hsa03040 | 0.45341982 |
| 114 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.45318539 |
| 115 | Endocytosis_Homo sapiens_hsa04144 | 0.45287588 |
| 116 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.44997275 |
| 117 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.44807848 |
| 118 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.43255754 |
| 119 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.43236061 |
| 120 | Viral myocarditis_Homo sapiens_hsa05416 | 0.43172205 |
| 121 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.41208739 |
| 122 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.40944867 |
| 123 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.40192988 |
| 124 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.38793309 |
| 125 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.36135202 |

